Arcutis Biotherapeutics Inc (ARQT) Earning Prediction
Arcutis Biotherapeutics Inc (ARQT) is set to release its earnings performance on 02/25 ET in After Hours trading. Consensus forecasts predict a revenue of 107.84M and an earnings per share (EPS) of 0.03 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
ARQT Transcript
The earnings call summary and Q&A provide a positive outlook. The company reported strong financial metrics, including a 28% QoQ sales growth and positive cash flow. ZORYVE's market expansion and upcoming approvals suggest future revenue growth. The Q&A highlighted optimism for pediatric opportunities and intellectual property strength. Despite some uncertainties in Medicare Part D coverage and IST study timelines, the overall sentiment remains positive with stable gross-to-net dynamics and strategic partnerships. Given the company's small-cap status, these factors are likely to result in a 2% to 8% stock price increase.
The earnings call reveals strong financial performance with a 196% YoY revenue increase and optimistic future prospects, including upcoming product launches and strategic partnerships. Despite regulatory and litigation risks, the company is addressing supply chain challenges and anticipates cash flow break-even by 2026. The market cap of approximately $1.09 billion suggests moderate volatility. The lack of a share repurchase program slightly tempers the outlook, but overall, the sentiment is positive, predicting a stock price increase of 2% to 8% over the next two weeks.
ARQT Slides
ARQT Report
Frequently Asked Questions
What is the Arcutis Biotherapeutics Inc Earnings Release Date and Time?
Arcutis Biotherapeutics Inc (ARQT) is scheduled to release its earnings report onFeb 25, 2026, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Arcutis Biotherapeutics Inc Revenue and EPS?
Analysts' consensus predicts 107.84M in revenue and an EPS of 0.03 for Arcutis Biotherapeutics Inc's .
What Does Intellectia's AI Predict for Arcutis Biotherapeutics Inc Earnings?
Intellectia's exclusive AI algorithms forecast a forArcutis Biotherapeutics Inc's earnings, with a prediction date of Feb 25, 2026. Arcutis Biotherapeutics Inc
How Can I Use This Earnings Prediction to Trade ARQT Stock?
Leverage Intellectia's AI forecast to position trades ahead of theFeb 25, 2026 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Arcutis Biotherapeutics Inc ?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
